GlassScriptPhysician profile
George S Predeteanu
NPI 1417944497
$15,253.72
in general payments reported to CMS, 2019-2025
50 companies · $2,502 in 2025
The $2,502 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,150 · 2020: $1,182 · 2021: $2,202 · 2022: $1,915 · 2023: $2,659 · 2024: $2,645 · 2025: $2,502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,805.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,814.41 | 2021-2025 | Corevalve Evolut R |
| Novartis Pharmaceuticals Corporation | $1,562.04 | 2019-2025 | |
| Amgen INC. | $1,128.32 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $857.01 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $705.83 | 2019-2025 | Wainua, Farxiga |
| Pfizer INC. | $703.09 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $688.83 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $657.63 | 2021-2025 | Verquvo |
| Medicure Pharma INC. | $643.87 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $624.29 | 2019-2025 | Opsumit, Uptravi |
| Janssen Pharmaceuticals, INC | $556.87 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $526.73 | 2022-2025 | Camzyos, Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $452.06 | 2021-2025 | |
| Abbott Laboratories | $419.44 | 2019-2025 | Cardiomems |
| Medtronic Vascular, INC. | $419.33 | 2019-2020 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $375.96 | 2020-2025 | Onpattro |
| Sanofi-Aventis U.S. LLC | $251.38 | 2019-2024 | |
| Boston Scientific Corporation | $246.83 | 2021-2023 | Watchman Flx, Watchman Access System, Bodyguardian |
| Amarin Pharma, INC. | $210.47 | 2019-2022 | |
| Lexicon Pharmaceuticals, INC. | $195.67 | 2023-2024 | Inpefa |
| Regeneron Healthcare Solutions, INC. | $191.08 | 2019-2022 | |
| Astellas Pharma US INC | $190.77 | 2019-2020 | |
| Novo Nordisk INC | $188.88 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Scpharmaceuticals INC. | $172.57 | 2024-2025 | |
| Abiomed | $154.39 | 2020-2025 | Impella |
| Kiniksa Pharmaceuticals, LTD. | $135.21 | 2022-2023 | Arcalyst |
| Arbor Pharmaceuticals, INC. | $133.85 | 2019-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $126.04 | 2024 | Arcalyst |
| Bridgebio Pharma, INC. | $115.15 | 2025 | Attruby |
| Esperion Therapeutics, INC. | $83.05 | 2020-2021 | |
| Daiichi Sankyo INC. | $76.58 | 2022-2023 | Injectafer |
| Inari Medical, INC. | $69.98 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Kestra Medical Technology Services, INC. | $67.46 | 2022-2024 | Assure Wcd |
| Acelrx Pharmaceuticals, INC. | $48.54 | 2021 | |
| Lundbeck LLC | $48.50 | 2019-2020 | |
| Edwards Lifesciences Corporation | $48.47 | 2021-2022 | |
| Irhythm Technologies, INC. | $45.72 | 2022-2023 | Zio Xt Patch |
| Biotronik INC. | $43.59 | 2021 | |
| Inspire Medical Systems, INC. | $40.27 | 2024 | Inspire |
| Elutia, INC. | $37.53 | 2021 | |
| Genzyme Corporation | $34.28 | 2019 | |
| Chiesi USA, INC. | $23.42 | 2019 | |
| Cardiovascular Systems INC. | $23.09 | 2020 | |
| Heartflow, INC. | $19.37 | 2025 | |
| Corcept Therapeutics | $19.23 | 2025 | Korlym |
| Getinge USA Sales, LLC | $16.93 | 2021 | |
| Cordis US Corp. | $16.34 | 2025 | Mynx Control |
| Baxter Healthcare | $16.23 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Amryt Pharma Holdings LTD | $16.18 | 2023 | Juxtapid |
| Kowa Pharmaceuticals America, INC. | $10.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Predeteanu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.